Mammogram rates increase after ACA eliminates co-payments

by Brown UniversityCredit: CC0 Public DomainAfter the Affordable Care Act (ACA) eliminated cost sharing for screening mammograms, their rate of use rose six percentage points among older woman fo

Updated on: March 27,2024

Mammogram rates increase after ACA eliminates co-payments

by Brown UniversityCredit: CC0 Public DomainAfter the Affordable Care Act (ACA) eliminated cost sharing for screening mammograms, their rate of use rose six percentage points among older woman fo

Updated on:March 27,2024

'Bone in a dish' opens new window on cancer initiation, metastasis, bone healing

by Oregon Health & Science UniversityLuiz Bertassoni D.D.S., Ph.D., and Avathamsa Athirasala, M.Sc.Eng., inspect the 3D mineral structure populated with living cells, providing a unique model

Updated on: March 13,2024

'Bone in a dish' opens new window on cancer initiation, metastasis, bone healing

by Oregon Health & Science UniversityLuiz Bertassoni D.D.S., Ph.D., and Avathamsa Athirasala, M.Sc.Eng., inspect the 3D mineral structure populated with living cells, providing a unique model

Updated on:March 13,2024

Selinexor for multiple myeloma receives accelerated FDA approval

by H. Lee Moffitt Cancer Center & Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A first-in-class d

Updated on: May 09,2024

Selinexor for multiple myeloma receives accelerated FDA approval

by H. Lee Moffitt Cancer Center & Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A first-in-class d

Updated on:May 09,2024

Research team creates more effective lymphatic cancer therapy

byTohoku UniversityThe ex vivo bioluminescence intensity of the metastatic LN was lowest in the Single M-TBI + LDDS group, followed by the Single M-TBI group and the LDDS group, and all these gr

Updated on: January 29,2024

Research team creates more effective lymphatic cancer therapy

byTohoku UniversityThe ex vivo bioluminescence intensity of the metastatic LN was lowest in the Single M-TBI + LDDS group, followed by the Single M-TBI group and the LDDS group, and all these gr

Updated on:January 29,2024

Experimental test promises to predict side-effects and cancer's return in patients treated with immunotherapy

by NYU Langone HealthCancer cell during cell division. Credit: National Institutes of HealthA single research test has the potential to predict which patients treated with immunotherapies—which h

Updated on: February 23,2024

Experimental test promises to predict side-effects and cancer's return in patients treated with immunotherapy

by NYU Langone HealthCancer cell during cell division. Credit: National Institutes of HealthA single research test has the potential to predict which patients treated with immunotherapies—which h

Updated on:February 23,2024

New biomarker shows potential to evaluate treatment response for metastatic colorectal cancer

by Germans Trias i Pujol Research InstituteGraphical abstract. Credit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.116857Colorectal cancer is the second leading caus

Updated on: July 17,2024

New biomarker shows potential to evaluate treatment response for metastatic colorectal cancer

by Germans Trias i Pujol Research InstituteGraphical abstract. Credit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.116857Colorectal cancer is the second leading caus

Updated on:July 17,2024

How do metastatic tumor cells grow in lymph nodes?

by Institute for Basic Science(Left) Schematic diagram for the mechanism of tumor lymph node metastasis.(Right) (A) Stepwise growing metastatic melanoma in tumor-draining lymph node and (B) fatty

Updated on: April 01,2024

How do metastatic tumor cells grow in lymph nodes?

by Institute for Basic Science(Left) Schematic diagram for the mechanism of tumor lymph node metastasis.(Right) (A) Stepwise growing metastatic melanoma in tumor-draining lymph node and (B) fatty

Updated on:April 01,2024

Topography of the genome influences where cancer mutations thrive, study shows

byUniversity of California - San DiegoJust as different terrains on Earth foster distinct ecosystems, certain topographic features in the genome seem to provide an environment for specific mutat

Updated on: January 22,2024

Topography of the genome influences where cancer mutations thrive, study shows

byUniversity of California - San DiegoJust as different terrains on Earth foster distinct ecosystems, certain topographic features in the genome seem to provide an environment for specific mutat

Updated on:January 22,2024

Bioengineers combine lab-on-a-chip technology with AI to improve cancer immunotherapy

byIndiana UniversityTheplatform tracks T cell infiltration of tumor spheroids, which are 3D structures made of cancer cells. Credit: Feng GuoAn interdisciplinary team of researchers led by

Updated on: January 04,2024

Bioengineers combine lab-on-a-chip technology with AI to improve cancer immunotherapy

byIndiana UniversityTheplatform tracks T cell infiltration of tumor spheroids, which are 3D structures made of cancer cells. Credit: Feng GuoAn interdisciplinary team of researchers led by

Updated on:January 04,2024

Alternative bladder cancer treatment emerges amid worldwide shortage of standard of care BCG

by Jennifer Brown,University of IowaCredit: CC0 Public DomainAn on-going, worldwide shortage of bacillus Calmette-Guérin (BCG) means that many patients with a common and serious type of bladder

Updated on: January 07,2024

Alternative bladder cancer treatment emerges amid worldwide shortage of standard of care BCG

by Jennifer Brown,University of IowaCredit: CC0 Public DomainAn on-going, worldwide shortage of bacillus Calmette-Guérin (BCG) means that many patients with a common and serious type of bladder

Updated on:January 07,2024

Fear of cancer recurrence common decades after surviving childhood cancer

by Lori SolomonA third of childhood cancer survivors experience fear of recurrence even decades later, according to a study published online Oct. 3 inJAMA Network Open.Alex Pizzo, from Concordia

Updated on: November 10,2024

Fear of cancer recurrence common decades after surviving childhood cancer

by Lori SolomonA third of childhood cancer survivors experience fear of recurrence even decades later, according to a study published online Oct. 3 inJAMA Network Open.Alex Pizzo, from Concordia

Updated on:November 10,2024

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on: March 30,2024

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on:March 30,2024